Your session is about to expire
← Back to Search
Pre-Incisional Ketorolac for Lung Cancer
Study Summary
This trialwill study if pre-surgery ketorolac can reduce the risk of distant tumor spread, potentially improving survival. 56 patients will get ketorolac, w/ 10 additional patients in a control group. Results will inform future studies on recurrence & survival.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Has Preoperative Ketorolac been researched in any previous experiments?
"Currently, there are 38 live clinical trials studying the use of Preoperative Ketorolac with 8 in Phase 3. These experiments predominantly take place in California's largest city but span across 57 different locations globally."
How many participants are currently being recruited for this clinical trial?
"Affirmative. Clinicaltrials.gov has verified that this clinical trial is currently recruiting participants, beginning with a post date of August 24th 2020 and last updated on October 10th 2022. 76 individuals need to be enrolled from 4 medical sites for the study."
Which individuals are eligible for participation in this clinical investigation?
"The requirements to be considered for this clinical trial include having renal cell carcinoma and being aged between 18-80. The research is looking to recruit a total of 76 individuals."
What therapeutic benefits does Preoperative Ketorolac provide?
"Ocular itching can be alleviated via the use of preoperative ketorolac, which has been proven to reduce pain, facilitate nerve block induction and regulate pupil size."
Are volunteers able to enroll in this experiment at the present time?
"As detailed on clinicaltrials.gov, this experiment is actively recruiting volunteers. It was first announced to the public on August 24th 2020 and its information was most recently updated October 10th 2022."
What are the aims of this experiment?
"This clinical trial, assessed over a Prior to Hospital Discharge window (which typically lasts up to 7 days after the surgical procedure), seeks to measure the Incidence of Postoperative Morbidity Rate Among Ketorolac Group. Additionally, secondary objectives encompass evaluating differences in Interleukin-1 alpha (IL-1alpha) Levels, Interleukin-2 (IL-2) Levels and Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Levels between study arms."
Does the age criterion for this experiment include individuals beyond four decades of life?
"This trial is looking for individuals aged 18 and older, but not exceeding 80 years of age."
Share this study with friends
Copy Link
Messenger